Company: PACB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001299130-25-000156
Chunk: 185

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 2
Chunk 185
---
 primarily comprised of interest on the convertible senior notes. The decrease was due to lower convertible notes balances as a result of the notes exchange transaction in November 2024. See Note 4. Convertible Senior Notes in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.

Other Income, Net

Other income, net for the second quarter of 2025 decreased compared to the same quarter of 2024 primarily driven by lower investment income due to lower cash and investment balances.

Q2 Fiscal 2025 Form 10-Q33

Comparison of the Six Months Ended June 30, 2025 and 2024

Six Months Ended June 30,(In thousands, except percentages)20252024$ Change% ChangeRevenue:Product revenue $64,196 $66,755 $(2,559)(4%)Service and other revenue 12,723 8,068 4,655 58%Total revenue 76,919 74,823 2,096 3%Cost of Revenue:Cost of product revenue 46,355 45,530 825 2%Cost of service and other revenue 8,631 7,104 1,527 21%Amortization of acquired intangible assets4,528 3,971 557 14%Loss on purchase commitment4,092 998 3,094 310%Total cost of revenue 63,606 57,603 6,003 10%Gross profit13,313 17,220 (3,907)(23%)Operating Expense:Research and development 51,582 81,940 (30,358)(37%)Sales, general and administrative 76,343 89,630 (13,287)(15%)Impairment charges15,000 93,200 (78,200)(84%)Amortization of acquired intangible assets362,875 9,728 353,147 3630%Change in fair value of contingent consideration(18,700)(70)(18,630)26614%Total operating expense 487,100 274,428 212,672 77%Operating loss (473,787)(257,208)(216,579)84%Interest expense (3,475)(7,117)3,642 (51%)Other income, net 8,990 12,828 (3,838)(30%)Loss before income taxes(468,272